Levels and durability of neutralizing antibodies against SARS-CoV-2 Omicron and other variants after ChAdOx-1 or BNT162b2 booster in CoronaVac-primed elderly individuals

The outbreak of the SARS-CoV-2 Omicron variant raised the need for vaccine boosting. We evaluated the efficiency of the third booster vaccine, ChAdOx-1 or BNT162b2, in causing a neutralizing antibody (NAb) response and its durability against the Omicron and other variants in elderly individuals prev...

Descripción completa

Detalles Bibliográficos
Autores principales: Takheaw, Nuchjira, Liwsrisakun, Chalerm, Laopajon, Witida, Pata, Supansa, Chaiwong, Warawut, Inchai, Juthamas, Duangjit, Pilaiporn, Pothirat, Chaicharn, Bumroongkit, Chaiwat, Deesomchok, Athavudh, Theerakittikul, Theerakorn, Limsukon, Atikun, Tajarernmuang, Pattraporn, Niyatiwatchanchai, Nutchanok, Trongtrakul, Konlawij, Kasinrerk, Watchara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10116116/
https://www.ncbi.nlm.nih.gov/pubmed/37095993
http://dx.doi.org/10.1016/j.heliyon.2023.e15653

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10116116/
https://www.ncbi.nlm.nih.gov/pubmed/37095993
http://dx.doi.org/10.1016/j.heliyon.2023.e15653

Ejemplares similares